Methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate, 98%, 25mg

(2,4,5-Trimethylphenyl)boronic acid, 95.0%, 5g

4-Oxo-4-(((R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl)oxy)butanoic acid, 98%, 100g

100 ml round bottle HDPE white RD 25 cylindrical

4-Amino-1-methylpiperidin-2-one hydrochloride, 95.0%, 500mg

4-amino-1-(2-methoxyethyl)-1,2-dihydropyridin-2-one hydrochloride, 97.0%, 250mg

1-(2-Hydroxyethyl)pyrimidine-2,4(1H,3H)-dione, 95.0%, 1g

5-(3,4-dimethylphenyl)-1,3,4-oxadiazol-2-amine, 95.0%, 2.5g

Dimethyl naphthalene-1,4-dicarboxylate, 98%, 500mg

2,2-Dimethyl-6,6,7,7,8,8,8-heptafluoro-3,5-octanedione, 98.0%, 1g

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 0.50 µm, 1 Piece(s)

2,6-Difluoronitrobenzene>98.0%(GC)1g

trans-4-n-Butylcyclohexanecarboxylic acid, 99.0%, 100g